Giant Biogene Sets 2026 AGM to Refresh Board Mandates and Appoint New Auditor

TipRanksMay 6 22:08

CSC Financial: Supply optimization is nearing completion; emphasize the revaluation of balance sheets.

The bank believes that during the 15th Five-Year Plan period, consumption will still require attention to niche alpha opportunities. On one hand, the logic of Chinese brands going global and consumption repatriation is becoming increasingly smooth; on the other hand, there are opportunities for balance sheet revaluation.

Zhitong FinanceMay 6 09:16

Giant Biogene Moves to Replace EY With KPMG as Auditor

TipRanksApr 30 21:02

Giant Biogene Holding Co. Ltd. (2367) Gets a Buy From Guotai Haitong

TipRanksApr 30 08:29 · Ratings

GIANT BIOGENE: ANNUAL REPORT 2025

HKEXApr 29 20:07 · Announcements

GIANT BIOGENE(2367.HK):MEDICAL AESTHETICS PIPELINE APPROVED AND LAUNCHED EXPECTED TO RETURN TO HEALTHY GROWTH

Apr 29 00:00